Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 1

Status

Completed 4Unknown 3Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 2Breast 2

Conditions

Motor Activity 2Breast Neoplasms 2Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × Wearable Electronic Devices × Clear all
NCT04736576 2024-11-22

JBCRG-26

Pfizer

Phase NA Completed
99 enrolled 47 charts
Breast

Breast Neoplasms, Motor Activity

NCT03773380 2022-03-04

BA

St. Joseph's Healthcare Hamilton

Phase 1 Completed
50 enrolled
Thoracic

Lung Neoplasms

NCT03902834 2019-04-08

Move for Surgery (MFS): Evaluating the Use of Wearable Technology for Preconditioning Before Thoracic Surgery

St. Joseph's Healthcare Hamilton

Phase NA Completed
25 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03072966 2019-01-10

Development of Distress Management Algorithms Using Mobile Device Based Health Logs in Breast Cancer Survivors

Asan Medical Center

Phase NA Completed
160 enrolled
Breast

Breast Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡